Chowdary, P <br/><br/>
Safety and pharmacokinetics of anti-TFPI antibody (concizumab) in healthy volunteers and patients with hemophilia: a randomized first human dose trial.  [electronic resource] 

 -  Journal of thrombosis and haemostasis : JTH  May 2015 
 - 743-54 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1538-7836 
<br/><br/><label>Standard No.: </label>10.1111/jth.12864  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Antibodies, Monoclonal, Humanized--adverse effects<br/>Area Under Curve<br/>Double-Blind Method<br/>Healthy Volunteers<br/>Hemophilia A--drug therapy<br/>Hemorrhage--chemically induced<br/>Humans<br/>Male<br/>Middle Aged<br/>Placebos<br/>Young Adult